Celebrating a Remarkable Achievement for miDiagnostics CEO

We are thrilled to announce that Katleen Verleysen, the CEO of miDiagnostics, has been awarded the prestigious title of European CEO of the Year 2024 in the accessible diagnostics technology sector by EU Business News. This esteemed recognition underscores her exceptional leadership and visionary approach in the field of diagnostic solutions.

Under Katleen’s guidance, miDiagnostics has made significant strides in revolutionizing the way diagnostic technologies are developed and implemented, ultimately enhancing patient care across the globe. Her commitment to innovation and excellence has not only propelled the company to new heights,but has also set a benchmark for the industry. This award serves as a testament to her dedication to improving healthcare accessibility and outcomes for patients everywhere.

We congratulate Katleen on this well-deserved honor and look forward to witnessing her continued impact on the future of healthcare.

View PDF

 

About miDiagnostics

miDiagnostics is using silicon chip technology which will bring miniaturized, rapid, easy-to-use, lab-quality tests direct to the patient and clinician. Combining a nanofluidic processor on a chip and a compact reader, miDiagnostics can measure virtually any biomarker from a minimally invasive sample such as drops of fingerprick blood or swabs.
The Company is developing an extensive portfolio of tests for screening, diagnosis and monitoring of a wide range of health conditions, including infectious diseases. Spun out of the world-leading R&D and innovation hub in nanoelectronics and digital technologies, imec, and a research collaboration with Johns Hopkins University, the leading US research and medical centre, miDiagnostics’ goal is to enable fast, comprehensive and cost-effective health analysis, regardless of location.  Based in Leuven, Belgium, miDiagnostics is a privately held company created in 2015.
Learn More

Share this story

Share This

Copy Link to Clipboard

Copy